All stock lists
Ferrari N.V. (New York Stock Exchange:RACE)
IT · Delayed Price · Currency is USD
Also listed: 2FE.DE, RACE.MI, RACE.SWConsumer Cyclical · Auto - Manufacturers
418.96+15.87 (+3.94%)
Market cap
$73.4B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 21, 2015
Website
Insider Score
––Not scored
RACE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
RACE analyst forecast
RACE analyst consensus
Moderate Buy2 ratings
Buy 2 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
RACE 12-month price target
$450.00+7.1% upsideaverage of 1 firm
$450.00High
$450.00Low
RACE ratings mix, last 12 months
Buy Hold Sell
Best analysts covering RACE
- Morgan Stanley86%success rate · +31.7% avg return · 14 calls
- UBS55%success rate · +5.8% avg return · 11 calls
- Bernstein50%success rate · +3.5% avg return · 2 calls
- JP Morgan0%success rate · -20.0% avg return · 2 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
RACE analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| UBS | Buy | $450.00 | +15.9% | Reiterated | 2026-10-05 | |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-09-30 |
| — | Bernstein | Outperform | — | — | Reiterated | 2026-07-31 |
| — | UBS | Buy | — | — | Reiterated | 2026-07-31 |
| — | UBS | Buy | — | — | Reiterated | 2026-07-02 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2026-06-15 |
| — | UBS | Buy | — | — | Reiterated | 2026-04-01 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-03-03 |
| — | UBS | Buy | — | — | Reiterated | 2026-01-09 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-11-12 |
| — | UBS | Buy | — | — | Reiterated | 2025-11-05 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-10-31 |
| — | UBS | Buy | — | — | Reiterated | 2025-10-16 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-10-16 |
| — | Bernstein | Outperform | — | — | Reiterated | 2025-10-10 |
| — | UBS | Buy | — | — | Reiterated | 2025-10-03 |
| — | HSBC | Buy | — | — | Upgraded | 2025-10-02 |
| — | UBS | Buy | — | — | Reiterated | 2025-09-03 |
| — | Deutsche Bank | Buy | — | — | Upgraded | 2025-09-02 |
| — | UBS | Buy | — | — | Reiterated | 2025-05-07 |
| — | UBS | Buy | — | — | Reiterated | 2025-04-01 |
| — | Barclays | Overweight | — | — | Upgraded | 2025-03-28 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-03-27 |
| — | Barclays | Equal Weight | — | — | Downgraded | 2025-02-05 |
| — | UBS | Buy | — | — | Reiterated | 2024-11-06 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2024-10-22 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2024-10-11 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2024-08-27 |
| — | Barclays | Overweight | — | — | Upgraded | 2024-08-02 |
| — | UBS | Buy | — | — | Reiterated | 2024-06-24 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2024-04-22 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2024-04-22 |
| — | Bernstein | Outperform | — | — | Reiterated | 2024-04-18 |
| — | B of A Securities | Buy | — | — | Reiterated | 2024-04-10 |
| — | Barclays | Equal Weight | — | — | Downgraded | 2024-04-04 |
| — | UBS | Buy | — | — | Reiterated | 2024-02-02 |
| — | Exane BNP Paribas | Neutral | — | — | Downgraded | 2023-12-13 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-11-03 |
| — | UBS | Buy | — | — | Reiterated | 2023-09-01 |
| — | Jefferies | Hold | — | — | Reiterated | 2023-08-25 |
| — | Bernstein | Market Perform | — | — | Reiterated | 2023-08-18 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-08-01 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-07-31 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-07-24 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-07-17 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-07-07 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-06-27 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-06-26 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2023-05-08 |
| — | CFRA | Strong Buy | — | — | Upgraded | 2023-05-05 |
| — | Goldman Sachs | Neutral | — | — | Upgraded | 2023-04-06 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-03-07 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2023-02-03 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2023-01-27 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2022-11-03 |
| — | HSBC | Buy | — | — | Upgraded | 2022-10-27 |
| — | UBS | Buy | — | — | Reiterated | 2022-08-03 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2022-05-24 |
| — | Exane BNP Paribas | Outperform | — | — | Upgraded | 2022-04-12 |
| — | UBS | Buy | — | — | Reiterated | 2022-04-04 |
RACE earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-10 | 2.44 | 2.49 | $2.08B | $2.12B |
| 2026-05-05 | 2.70 | 2.73 | $2.12B | $2.14B |
| 2026-07-30 | 2.83 | 2.99 | $2.14B | $2.21B |
| 2026-11-03 | 2.66 | 0.00 | $2.15B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.